Cargando…

No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation

INTRODUCTION: In alcoholic hepatitis (AH), translocation of gut bacteria may drive hepatic macrophage activation and systemic inflammation. We investigated the effect of oral non-absorbable, broad-spectrum antibiotic treatment on bacterial translocation and liver and systemic inflammation in AH. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Støy, Sidsel, Laursen, Tea Lund, Eriksen, Lotte Lindgreen, Grønbæk, Henning, Vilstrup, Hendrik, Sandahl, Thomas Damgaard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846454/ https://www.ncbi.nlm.nih.gov/pubmed/33566559 http://dx.doi.org/10.14309/ctg.0000000000000306

Ejemplares similares

Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis
por: Eriksen, Lotte Lindgreen, et al.
Publicado: (2021)

The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2017)

Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course
por: Støy, Sidsel, et al.
Publicado: (2013)

High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
por: Björklund, Jessica, et al.
Publicado: (2018)

Diminished Non-Classical Monocytes in the Blood Associate with Disease Severity in Alcoholic Hepatitis
por: Rasmussen, Elisabeth Busk, et al.
Publicado: (2021)

Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis
por: Støy, Sidsel, et al.
Publicado: (2018)

Low Interleukin-22 Binding Protein Is Associated With High Mortality in Alcoholic Hepatitis and Modulates Interleukin-22 Receptor Expression
por: Støy, Sidsel, et al.
Publicado: (2020)

Correction: Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis
por: Støy, Sidsel, et al.
Publicado: (2018)

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
por: Lauszus, Johanne Sloth, et al.
Publicado: (2021)

Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study
por: Munk, Ditte Emilie, et al.
Publicado: (2022)

Liver-related effects of chronic hepatitis C antiviral treatment
por: Laursen, Tea L, et al.
Publicado: (2020)

Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis
por: Glavind, Emilie, et al.
Publicado: (2016)

Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection
por: Eriksen, Lotte Lindgreen, et al.
Publicado: (2021)

Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases
por: Laursen, Tea Lund, et al.
Publicado: (2022)

Isolated congenital hepatic fibrosis associated with TMEM67 mutations: report of a new genotype–phenotype relationship
por: Vogel, Ida, et al.
Publicado: (2017)

Effect of broad-spectrum antibiotics on bacterial translocation in burned or septic rats
por: Wen, Zhen-Liang, et al.
Publicado: (2019)

Update on the Therapeutic Management of Hepatic Encephalopathy
por: Kornerup, Linda Skibsted, et al.
Publicado: (2018)

Clinical Progression of Metabolic-Associated Fatty Liver Disease Is Rare in a Danish Tertiary Liver Center
por: Laursen, Tea Lund, et al.
Publicado: (2022)

Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy?
por: Kornerup, Linda Skibsted, et al.
Publicado: (2019)

Portal vein thrombosis; risk factors, clinical presentation and treatment
por: Sogaard, Kirstine K, et al.
Publicado: (2007)

The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia – a historical cohort study
por: Jepsen, Peter, et al.
Publicado: (2012)

Designer broad-spectrum polyimidazolium antibiotics
por: Zhong, Wenbin, et al.
Publicado: (2020)

Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention
por: Carstens, Jan, et al.
Publicado: (2007)

Impaired hepatic counterregulatory response to insulin-induced hypoglycemia in hepatic denervated pigs
por: Nielsen, Michael Festersen, et al.
Publicado: (2015)

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease
por: Glavind, Emilie, et al.
Publicado: (2020)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

Comparison of broad-spectrum antibiotics and narrow-spectrum antibiotics in the treatment of lower extremity cellulitis
por: Almulhim, Abdulaziz Saleh, et al.
Publicado: (2018)

Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
por: Laursen, Tea L, et al.
Publicado: (2019)

The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2(☆)
por: Lee, James, et al.
Publicado: (2013)

Development and validation of the Cirrhotic Ascites Severity model—A patient‐reported outcome‐based model to predict 1‐year mortality
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022)

Characteristics of doripenem: a new broad-spectrum antibiotic
por: Alvarez-Lerma, Francisco, et al.
Publicado: (2009)

In the era of broad spectrum antibiotics, is ampicillin still an option?
por: Popescu, Cristina, et al.
Publicado: (2013)

Less empiric broad-spectrum antibiotics is more in the ICU
por: da Fonseca Pestana Ribeiro, Jose Mauro, et al.
Publicado: (2019)

2281 Prophylactic broad-spectrum antibiotics for childhood malnutrition
por: Langdon, Amy Elizabeth, et al.
Publicado: (2018)

JMM Profile: Carbapenems: a broad-spectrum antibiotic
por: Armstrong, Tom, et al.
Publicado: (2021)

Broad spectrum antibiotic stewardship by quality improvement methods
por: Niazi-Ali, Saarah, et al.
Publicado: (2022)

Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study
por: Ladegaard Grønkjær, Lea, et al.
Publicado: (2018)

Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study
por: Jepsen, Peter, et al.
Publicado: (2016)

Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [(64)Cu]copper PET/CT
por: Kjærgaard, Kristoffer, et al.
Publicado: (2020)

Targeting an Essential GTPase Obg for the Development of Broad-Spectrum Antibiotics
por: Bonventre, Josephine A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c71kaj7d7j38u0tgvvfsa1bg20